Back

Induced pluripotent stem cells as a biopharmaceutical factory for extracellular vesicles

European Heart Journal

13 March 2018
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Abstract

Abstract

Contributors

Masataka Nishiga
Masataka Nishiga

Author

Hongchao Guo
Hongchao Guo

Author

Joseph C Wu
Joseph C Wu

Author

Stanford University School of Medicine Stanford , United States of America

You may be interested in
thumbnail
Congress Presentation
Extracellular vesicles derived from hyaluronic acid primed induced pluripotent stem cell derived mesenchymal stem cell can ameliorate the heart function.
20 May 2023
thumbnail
Congress Presentation
Innovating biomaterials for tissue repair, advanced therapeutics and early disease detection
31 August 2024
thumbnail
Congress Presentation
In vitro platform to model anthracycline-induced cardiotoxicity and evaluate cardioprotective agents in human -induced pluripotent stem cells-derived cardiomyocytes
20 June 2025
thumbnail
Webinar
Induced-pluripotent stem cells (iPSC) technology for cardiac repair
17 March 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources